Answers are grounded in this paper and cite their sources.
Background: Obstructive sleep apnea (OSA) has been associated with adverse cardiometabolic profiles, but its relationship with cholesterol target attainment in patients receiving lipid-lowering therapy remains incompletely characterized. We investigated the association between severe OSA and non-attainment of predefined cholesterol thresholds in patients undergoing elective cardiac surgery. Methods: This secondary analysis included 142 adults from a prospectively assembled observational cohort. Participants underwent in-hospital preoperative Type III cardiorespiratory polygraphy, fasting lipid assessment, and documentation of lipid-lowering therapy. Severe OSA was defined as an apnea–hypopnea index ≥30 events/h. The primary outcome was non-high-density lipoprotein cholesterol (non-HDL-C) ≥ 100 mg/dL. Multivariable models were adjusted for age, sex, body mass index, diabetes mellitus, high-intensity statin therapy, and non-statin lipid-lowering therapy. Results: Severe OSA was associated with higher odds of non-HDL-C ≥ 100 mg/dL (adjusted odds ratio [OR] 3.49, 95% confidence interval [CI] 1.56–7.78; p = 0.002), LDL-C ≥ 55 mg/dL (OR 2.93, 95% CI 1.18–7.29; p = 0.021), and LDL-C ≥ 70 mg/dL (OR 2.30, 95% CI 1.03–5.12; p = 0.041). In contrast, associations with continuous LDL-C (p = 0.113) and non-HDL-C (p = 0.100) concentrations were not statistically significant. No significant associations were observed for triglyceride-related or lipid-derived outcomes. The primary association with non-HDL-C ≥ 100 mg/dL remained significant in the analysis restricted to statin-treated patients. Conclusions: Severe OSA was associated with non-attainment of predefined cholesterol thresholds in this cardiac surgical cohort, with the strongest and most consistent association observed for non-HDL-C ≥ 100 mg/dL. These findings identify an association with categorical cholesterol target non-attainment but do not establish treatment failure, causality, or a generalized increase in cholesterol concentrations.
No takes yet. Share an insight, caveat, or question.
Manzur et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: